~ Recognized by Government of Maharashtra for Advancing Breast Cancer Treatment ~
2nd May 2025 – Shashvi Remedies Pvt. Ltd., an emerging healthcare innovator, has been awarded a grant of Rs. 10 lakhs by the Maharashtra State Innovation Society (MSINS) under the Department of Skill Development and Entrepreneurship. The grant supports the company’s internationally awarded patents in breast cancer treatment, marking a significant endorsement of its work in oncology innovation.
With breast cancer affecting over 670,000 women globally each year—and one woman diagnosed every four minutes in India—Shashvi’s patented technology offers a novel approach by selectively targeting cancer cells while preserving healthy tissue, improving outcomes and quality of life for patients.
The innovation arrives at a pivotal time as the global pharmaceutical industry prepares for the 2030 patent cliff, with over $500 billion in reserves poised for investment in novel oncology assets. Shashvi’s breakthrough positions it strategically for partnerships or acquisition, reflecting growing industry interest in early-stage, high-impact cancer therapies.
Citing recent market activity, a top Indian pharma firm’s $355 million acquisition of a U.S. derma-oncology innovator underscores the demand for transformative cancer solutions.
Mrs. Sonal Bansal, Founder of Shashvi Remedies, stated: “We are honoured to receive this grant from MSINS, this has validated our attempt to turning scientific breakthrough into real world impact. Setting a new benchmark from day one, our latest breast cancer innovation, making breast cancer preventable and treatment more accessible and less daunting for patients. As India advances towards becoming a global powerhouse in healthcare, Shashvi Remedies stands at the forefront in driving innovation into impact for a healthier tomorrow.”
The recognition signals India’s growing leadership in healthcare innovation and reinforces Shashvi Remedies’ role in shaping inclusive, patient-focused cancer care solutions.
